Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Scilex Holding Company

SCLXNASDAQ
Healthcare
Drug Manufacturers - General
$7.84
$-0.17(-2.12%)
U.S. Market is Open • 14:28

Scilex Holding Company Fundamental Analysis

Scilex Holding Company (SCLX) shows moderate financial fundamentals with a PE ratio of -0.25, profit margin of -9.31%, and ROE of 1.81%. The company generates $0.0B in annual revenue with strong year-over-year growth of 21.07%.

Key Strengths

PEG Ratio0.00

Areas of Concern

ROE1.81%
Operating Margin-6.52%
Cash Position0.93%
Current Ratio0.05
We analyze SCLX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -631.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-631.3/100

We analyze SCLX's fundamental strength across five key dimensions:

Efficiency Score

Weak

SCLX struggles to generate sufficient returns from assets.

ROA > 10%
-1.36%

Valuation Score

Excellent

SCLX trades at attractive valuation levels.

PE < 25
-0.25
PEG Ratio < 2
0.00

Growth Score

Excellent

SCLX delivers strong and consistent growth momentum.

Revenue Growth > 5%
21.07%
EPS Growth > 10%
56.68%

Financial Health Score

Moderate

SCLX shows balanced financial health with some risks.

Debt/Equity < 1
-0.38
Current Ratio > 1
0.05

Profitability Score

Moderate

SCLX maintains healthy but balanced margins.

ROE > 15%
181.11%
Net Margin ≥ 15%
-9.31%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SCLX Expensive or Cheap?

P/E Ratio

SCLX trades at -0.25 times earnings. This suggests potential undervaluation.

-0.25

PEG Ratio

When adjusting for growth, SCLX's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Scilex Holding Company at -0.52 times its book value. This may indicate undervaluation.

-0.52

EV/EBITDA

Enterprise value stands at -0.00 times EBITDA. This is generally considered low.

-0.00

How Well Does SCLX Make Money?

Net Profit Margin

For every $100 in sales, Scilex Holding Company keeps $-9.31 as profit after all expenses.

-9.31%

Operating Margin

Core operations generate -6.52 in profit for every $100 in revenue, before interest and taxes.

-6.52%

ROE

Management delivers $1.81 in profit for every $100 of shareholder equity.

1.81%

ROA

Scilex Holding Company generates $-1.36 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.36%

Following the Money - Real Cash Generation

Operating Cash Flow

Scilex Holding Company generates strong operating cash flow of $17.53M, reflecting robust business health.

$17.53M

Free Cash Flow

Scilex Holding Company generates strong free cash flow of $17.53M, providing ample flexibility for dividends, buybacks, or growth.

$17.53M

FCF Per Share

Each share generates $2.05 in free cash annually.

$2.05

FCF Yield

SCLX converts 34.54% of its market value into free cash.

34.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.25

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.001

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.52

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.69

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.05

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.81

vs 25 benchmark

ROA

Return on assets percentage

-1.36

vs 25 benchmark

ROCE

Return on capital employed

3.17

vs 25 benchmark

How SCLX Stacks Against Its Sector Peers

MetricSCLX ValueSector AveragePerformance
P/E Ratio-0.2529.43 Better (Cheaper)
ROE181.11%800.00% Weak
Net Margin-931.21%-20145.00% (disorted) Weak
Debt/Equity-0.380.30 Strong (Low Leverage)
Current Ratio0.054.64 Weak Liquidity
ROA-136.23%-17936.00% (disorted) Weak

SCLX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Scilex Holding Company's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

56.02%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

76.36%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

118.57%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ